The Centers for Disease Control and Prevention today identified vitamin E acetate as a “potential chemical of concern” in biologic samples from patients with vaping-associated lung injuries. The agency tested lung fluid samples from 29 patients with the condition (called EVALI) in 10 states and found vitamin E acetate in all 29 samples. “These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs,” CDC said. It also found tetrahydrocannabinol (THC) in 82% of the samples and nicotine in 62% of the samples. CDC yesterday updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 2,051 in 49 states, the District of Columbia and the U.S. Virgin Islands, including 39 confirmed deaths. CDC and the Food and Drug Administration continue to investigate the cause of the illness, and encourage health care providers to report possible cases to their state or local health department.

Related News Articles

Headline
The Cell and Gene Therapy Access Model, which seeks to increase access to treatments for Medicaid enrollees with rare and severe diseases, will initially focus…
Headline
The Centers for Disease Control and Prevention is following up on a previous alert of an outbreak of suspected fungal meningitis in Texas, which is now…
Headline
The U.S. Preventive Services Task Force yesterday released for public comment through June 5 a draft recommendation that all women get screened for breast…
Headline
In the latest podcast in AHA’s Advancing Health podcast series on leading initiatives to transform care and advance equity, leaders from Montage Health and…
Headline
The recent paralytic polio case in an unvaccinated adult in Rockland County, N.Y. and wastewater samples from communities near the patient’s residence meet the…
Headline
The Centers for Disease Control and Prevention late yesterday confirmed a case of human monkeypox in a U.S. resident who recently traveled from Nigeria to…